ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

MESO Mesoblast Limited

7,21
0,61 (9,24%)
02 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Mesoblast Limited MESO NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
0,61 9,24% 7,21 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
7,06 7,00 7,3732 7,21 6,60
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202403:05GLOBEAppendix 4c Quarterly Activity Report for Quarter Ended..
26.3.202414:25APSFDA Commentary Sends Biotech Soaring During Premarket Hours
26.3.202403:34GLOBEUnited States Food & Drug Administration (FDA) Notifies..
14.3.202400:30GLOBEMesoblast Successfully Completes Placement and Accelerated..
11.3.202400:54GLOBEUnited States Food & Drug Administration (FDA) Supports..
28.2.202423:57GLOBEMesoblast Reports Financial Results and Operational Update..
26.2.202413:00GLOBEMesoblast Financial Results and Corporate Update Webcast
15.2.202401:46GLOBEUnited States Food & Drug Administration (FDA) Grants..
01.2.202403:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31.1.202403:13GLOBEAppendix 4C Quarterly Activity Report for Quarter Ended..
19.1.202401:28DJNMesoblast Gets FDA's Special Pediatric Designation for..
19.1.202400:36GLOBEUnited States Food & Drug Administration (FDA) Grants..
16.1.202412:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05.1.202403:57EDGAR2Form F-6 POS - Post-effective amendments for immediately..
22.12.202323:13EDGAR2Form F-6 POS - Post-effective amendments for immediately..
27.11.202300:56GLOBEMesoblast Files for Orphan Drug and Pediatric Rare Disease..
22.11.202319:35APSBiotech Shares Soar Following Major Announcement
22.11.202300:32GLOBEMesoblast Partners With Blood and Marrow Transplant Clinical..
31.10.202301:04GLOBEAppendix 4C Quarterly Activity Report for Quarter Ended..
26.9.202312:18GLOBEJane Bell AM Appointed Chair of Mesoblast Audit and Risk..
21.9.202309:30GLOBEKey Outcomes From FDA Type A Meeting and Mesoblast Next..
06.9.202312:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31.8.202301:07GLOBEMesoblast Reports Financial Results and Operational Update..
29.8.202313:00GLOBEMesoblast Financial Results and Corporate Update Webcast
04.8.202315:03DJNMesoblast ADSs Plunge Premarket on Latest FDA Rejection
04.8.202302:10GLOBEMesoblast Receives Complete Response From U.S. Food and Drug..
31.7.202302:31GLOBEAppendix 4C Quarterly Activity Report for Quarter Ended June..
05.6.202302:21GLOBEMesoblast Director Philip R. Krause, M.D., Appointed to..
26.5.202301:28GLOBEMesoblast Reports Operational and Financial Highlights for..
24.5.202313:00GLOBEMesoblast Financial Results and Corporate Update Webcast

Kürzlich von Ihnen besucht

Delayed Upgrade Clock